189 related articles for article (PubMed ID: 20973774)
1. Co-operative signalling through DP(1) and DP(2) prostanoid receptors is required to enhance leukotriene C(4) synthesis induced by prostaglandin D(2) in eosinophils.
Mesquita-Santos FP; Bakker-Abreu I; Luna-Gomes T; Bozza PT; Diaz BL; Bandeira-Melo C
Br J Pharmacol; 2011 Apr; 162(8):1674-85. PubMed ID: 20973774
[TBL] [Abstract][Full Text] [Related]
2. R2D(2) for C(4)Eo: an 'alliance' of PGD(2) receptors is required for LTC(4) production by human eosinophils.
Mackay GA; Stewart AG
Br J Pharmacol; 2011 Apr; 162(8):1671-3. PubMed ID: 21426314
[TBL] [Abstract][Full Text] [Related]
3. Leptin Elicits LTC
Amorim NRT; Luna-Gomes T; Gama-Almeida M; Souza-Almeida G; Canetti C; Diaz BL; Weller PF; Torres Bozza P; Maya-Monteiro CM; Bandeira-Melo C
Front Immunol; 2018; 9():2139. PubMed ID: 30298073
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.
Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG
J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101
[TBL] [Abstract][Full Text] [Related]
5. D-type prostanoid receptor enhances the signaling of chemoattractant receptor-homologous molecule expressed on T(H)2 cells.
Sedej M; Schröder R; Bell K; Platzer W; Vukoja A; Kostenis E; Heinemann A; Waldhoer M
J Allergy Clin Immunol; 2012 Feb; 129(2):492-500, 500.e1-9. PubMed ID: 21930295
[TBL] [Abstract][Full Text] [Related]
6. CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases.
Schuligoi R; Sturm E; Luschnig P; Konya V; Philipose S; Sedej M; Waldhoer M; Peskar BA; Heinemann A
Pharmacology; 2010; 85(6):372-82. PubMed ID: 20559016
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin D2-DP signaling promotes endothelial barrier function via the cAMP/PKA/Tiam1/Rac1 pathway.
Kobayashi K; Tsubosaka Y; Hori M; Narumiya S; Ozaki H; Murata T
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):565-71. PubMed ID: 23307871
[TBL] [Abstract][Full Text] [Related]
8. Schistosomal Lipids Activate Human Eosinophils via Toll-Like Receptor 2 and PGD
Magalhães KG; Luna-Gomes T; Mesquita-Santos F; Corrêa R; Assunção LS; Atella GC; Weller PF; Bandeira-Melo C; Bozza PT
Front Immunol; 2018; 9():3161. PubMed ID: 30740113
[TBL] [Abstract][Full Text] [Related]
9. Eosinophils and cysteinyl leukotrienes.
Bandeira-Melo C; Weller PF
Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):135-43. PubMed ID: 12895596
[TBL] [Abstract][Full Text] [Related]
10. The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes.
Nagata K; Hirai H
Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):169-77. PubMed ID: 12895600
[TBL] [Abstract][Full Text] [Related]
11. Eosinophils as a novel cell source of prostaglandin D2: autocrine role in allergic inflammation.
Luna-Gomes T; Magalhães KG; Mesquita-Santos FP; Bakker-Abreu I; Samico RF; Molinaro R; Calheiros AS; Diaz BL; Bozza PT; Weller PF; Bandeira-Melo C
J Immunol; 2011 Dec; 187(12):6518-26. PubMed ID: 22102725
[TBL] [Abstract][Full Text] [Related]
12. A novel PGD(2) receptor expressed in eosinophils.
Powell WS
Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):179-85. PubMed ID: 12895601
[TBL] [Abstract][Full Text] [Related]
13. Expression of DP2 (CRTh2), a prostaglandin D₂ receptor, in human mast cells.
Moon TC; Campos-Alberto E; Yoshimura T; Bredo G; Rieger AM; Puttagunta L; Barreda DR; Befus AD; Cameron L
PLoS One; 2014; 9(9):e108595. PubMed ID: 25268140
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin D2 induces IL-8 and GM-CSF by bronchial epithelial cells in a CRTH2-independent pathway.
Chiba T; Kanda A; Ueki S; Ito W; Kamada Y; Oyamada H; Saito N; Kayaba H; Chihara J
Int Arch Allergy Immunol; 2006; 141(3):300-7. PubMed ID: 16940740
[TBL] [Abstract][Full Text] [Related]
15. Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors.
Gallant MA; Samadfam R; Hackett JA; Antoniou J; Parent JL; de Brum-Fernandes AJ
J Bone Miner Res; 2005 Apr; 20(4):672-81. PubMed ID: 15765187
[TBL] [Abstract][Full Text] [Related]
16. Intracrine cysteinyl leukotriene receptor-mediated signaling of eosinophil vesicular transport-mediated interleukin-4 secretion.
Bandeira-Melo C; Woods LJ; Phoofolo M; Weller PF
J Exp Med; 2002 Sep; 196(6):841-50. PubMed ID: 12235216
[TBL] [Abstract][Full Text] [Related]
17. Antagonists of the prostaglandin D2 receptor CRTH2.
Pettipher R; Hansel TT
Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589
[TBL] [Abstract][Full Text] [Related]
18. The opposing role of two prostaglandin D2 receptors, DP and CRTH2, in human eosinophil migration.
Chiba T; Ueki S; Ito W; Kato H; Kamada R; Takeda M; Kayaba H; Furue M; Chihara J
Ann Allergy Asthma Immunol; 2011 Jun; 106(6):511-7. PubMed ID: 21624751
[TBL] [Abstract][Full Text] [Related]
19. 15-Deoxy-delta 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils.
Monneret G; Li H; Vasilescu J; Rokach J; Powell WS
J Immunol; 2002 Apr; 168(7):3563-9. PubMed ID: 11907120
[TBL] [Abstract][Full Text] [Related]
20. The extracellular signal-regulated kinase mitogen-activated protein kinase/ribosomal S6 protein kinase 1 cascade phosphorylates cAMP response element-binding protein to induce MUC5B gene expression via D-prostanoid receptor signaling.
Choi YH; Lee SN; Aoyagi H; Yamasaki Y; Yoo JY; Park B; Shin DM; Yoon HG; Yoon JH
J Biol Chem; 2011 Sep; 286(39):34199-214. PubMed ID: 21832046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
